Liu, Jianying
Liu, Yang
Xia, Hongjie http://orcid.org/0000-0002-2520-7038
Zou, Jing
Weaver, Scott C. http://orcid.org/0000-0001-8016-8556
Swanson, Kena A.
Cai, Hui
Cutler, Mark
Cooper, David http://orcid.org/0000-0002-4595-3943
Muik, Alexander http://orcid.org/0000-0003-4561-2273
Jansen, Kathrin U. http://orcid.org/0000-0001-5354-4202
Sahin, Ugur
Xie, Xuping http://orcid.org/0000-0003-0918-016X
Dormitzer, Philip R. http://orcid.org/0000-0003-0671-6360
Shi, Pei-Yong http://orcid.org/0000-0001-5553-1616
Article History
Received: 29 September 2021
Accepted: 15 March 2022
First Online: 8 April 2022
Competing interests
: The authors declare that there are no competing interests. X.X. and P.-Y.S. have filed a patent on the reverse genetic system and reporter of SARS-CoV-2. K.A.S., H.C., M.C., D.C., K.U.J., and P.R.D. are employees of Pfizer and may hold stock options. A.M. and U.S. are employees of BioNTech and may hold stock options. Y.L., H.X., J.Z., X.X., and P.-Y.S. received compensation from Pfizer to perform the neutralization assay.